HIGHLIGHTS
- who: . and collaborators from the China Fudan University, China have published the research: Pharmacological mechanisms of Fuzheng Huayu formula for Aristolochic acid I induced kidney brosis through network pharmacology, in the Journal: (JOURNAL)
- what: The research shows that FZHY could alleviate AAI-induced renal injuries and inflammatory responses through the MAPK/FOS signaling pathways . A randomized, double-blind, multicenter clinical trial was conducted to evaluate the efficacy of FZHY for CKD (2019ZX09201001-001-006). The authors identified 815 genes that were differentially expressed in patients with CKD compared with normal individuals in their kidney tissues . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.